Research & Development: Page 88

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Sales Training Consultancy Formed New consultancy launched to improve pharmaceutical training success. For pharmaceutical training professionals struggling to wade through the array of vendor pitches for products and services, Impactiviti LLC, led by industry veteran Steve Woodruff, founder, cons...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    BBK Launches E-Business Suite of Tools for Patient Recruitment Pharmaceutical, medical-device, and biotechnology companies can now take advantage of BBK Worldwide’s TCN e-Systems, a licensable e-business patient-recruitment solutions offering. With TCN e-Systems, study sponsors have greater contr...

    By PharmaVoice Team • Jan. 2, 2008
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor -- A Year in Preview

    As another year comes to a close, it’s natural to stop and take stock of the events that have shaped the industry and to look ahead in anticipation of what’s next on the horizon. Once again, PharmaVOICE appreciates the time that so many industry executives took out of their busy schedules to comm...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Investigator Training

    Year in Preview 12 Ways to Improve Training for Clinical Studies training for clinical studies Investigator meetings are, in fact, training sessions. But there is a tremendous gap between current prevailing practices and best practices in preparing study sites to conduct individual clinical trial...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Year in Preview Then & Now Thought leaders review their 2005 predictions for 2006. The Discovery process Balancing scientific breakthroughs with ethical and safety issues. investigator training Best practices for preparing study sites for clinical trials. A new paradigm for clinical developme...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Discovery Process

    Year in Preview Human embryonic stem cells (hESC), proteomics, molecular profiling, and other cutting-edge technologies are generating excitement in the lab as scientists continue to balance scientific breakthroughs with ethical and safety development issues. scientific breakthroughs Before a dru...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Year in Preview -- Featured Thought Leaders

    Year in Preview Thought leaders Indexed by Section What the Future Holds Richard Gliklich, M.D., President and CEO, Outcome Simon S. Higginbotham, VP and Chief Marketing Officer, Kendle Ravi Kiron, Ph.D., MBA, Pharma/Biotech Strategy Executive, Formerly Alza Corp. John Potthoff, Ph.D., Chief Oper...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Year in Preview -- Featured Thought Leaders

    Thought leaders Indexed by Company Affiliation Adair-Greene Healthcare Communications Mark S. Perlotto Advanced Cell Technology Inc. William M. Caldwell IV Advanstar Communications Inc. Andrew Weissberg Advaxis Inc. John Rothman, Ph.D. Aerovance Inc. William J. Newell, J.D. Ariad Pharmaceuticals ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Crystal Ball

    What the Future Holds As PharmaVOICE presents its third annual Year in Preview issue, we asked our readers to look forward and provide us with their insights on the hot issues, topics, and trends that they think will impact the life-sciences/pharmaceutical industry in 2007. This is their chance t...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Adaptive Clinical Trials Technology is the Driving Force

    Adaptive Clinical Trials Technology is the Driving Force Richard Piazza, MS, Pharm.D., VP, Product Strategy October 2006 VIEW on E-Solutions Modern medicine is headed down a path of rapid growth and development and increased efficiency. The FDA and the industry as a whole are looking ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    E-solutions have come a long way, but life-sciences companies are still taking baby steps compared with other industries. Good or bad, regulatory restrictions, particularly regarding privacy and security issues, are holding companies back. The industry, however, is working through these issues. ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    VIEW on E-Solutions October 2006 Letter from the Managing Editor The Forum E-Solutions: Adoption is a Marathon not a Sprint — Pharmaceutical and biotech companies recognize the numerous benefits e-solutions can bring to their operations, but implementation is easier said than done. Company Listin...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Integrated eClinical Solutions: Be Afraid, Be Very Afraid…

    Integrated eClinical Solutions: Be Afraid, Be Very Afraid… Timothy Pratt, Ph.D. Chief Marketing Officer and Principal Scientific Advisor Why are lots of EDC vendors talking about how integrated their systems are? And what’s this new buzzword emerging — eClinical? Is this just EDC? Why sho...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Metrics: It's All About Performance

    By Taren Grom, Editor From the clinic to the market, the ability to drive process improvement and operational excellence for sponsors and providers through strategic metrics has never been more important. Metrics encourage effectiveness, efficiencies, and appropriate levels of control. No matter ...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Letters

    A refreshing focus Pending patent expirations, the FDA, compliance issues, product liability and related lawsuits, stock price pressures, fully integrated and targeted promotion, return on promotional investment, accountability, fair balance, mergers and consolidations, salesforce effectiveness, ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Calculated Risks -- Bassil Dahiyat

    In a business climate in which caution and proven outcomes dominate, Bassil Dahiyat, Ph.D., is a daring and enthusiastic exception to the rule. Risk is not a word that frightens the young entrepreneur. He founded his own company, Xencor Inc., directly after completing his Ph.D., based on the prot...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    GSW Launches Pink Tank Specialty marketing group offers expertise in understanding and speaking to women. Remarkably, many marketers don’t realize that women connect with brands differently from men. We established Pink Tank to help companies understand those differences and to counsel them on ho...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    Industry Events October 2006 Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pink Ribbons of Opportunity

    By Cynthia Borda Despite advances in breast cancer treatments, this is still an area of unmet need. Significant opportunities exist in this market, especially for products that are targeted and that have fewer side effects. Tremendous progress has been made in treating breast cancer. Survival rat...

    By Cynthia Borda • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    resource hub Grand Opening of the Pennsylvania Biotechnology Center The Pennsylvania Biotechnology Center of Bucks County located in Doylestown, Pa., is a $15 million, 62,000-square-foot facility, funded in part by a grant from the Commonwealth of Pennsylvania. The center seeks to advance biotech...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Technology Use Among Regulatory Affairs Professionals Rising Many regulatory affairs professionals rely on both paper and electronic submissions, and 70% of these professionals expect this trend to continue into the future, according to ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Bio Meets Pharma to Form the New Age of Biopharma

    By Denise Myshko In the future, broad-based companies will choose the most appropriate approach, whether small molecule or biologic, to create new interventions. The distinction between biotech and pharma is blurring. The result: broad-based companies use their expertise in a disease and the unde...

    By Denise Myshko • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    A.J. Kazimi says public perception is one obstacle midsize companies face. Jill Balderson says patients need more information about diseases. Dr. Dahiyat’s technology could change the face of medicine. October 2006 PharmaVOICE On the Cover Midsize pharma: Moving and shaking the industry Unlike th...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    October is National Breast Cancer Awareness Month. We at PharmaVOICE thought it appropriate, therefore, to focus this month’s therapeutic specialty on this important area of research and treatment. According to the American Cancer Society, breast cancer death rates are going down. The chance of d...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies InfoMedics’ Treatment Educator Improves Patient Understanding and Increases Brand Loyalty InfoMedics Inc. has released Treatment Educator, a tool for improving prescription compliance through patient education and treatment unders...

    By PharmaVoice Team • Jan. 2, 2008